Evidence map›Paper›PMID 37938343›Full record

ArticleCurrent genetics2023

Tips for efficiently maintaining pET expression plasmids.

Diana Khananisho, Alister J Cumming, Daria Kulakova, Patrick J Shilling, Daniel O Daley

Open access · hybridAbstract read
In one paragraph

Article in Current genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Diana Khananisho *Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Alister J Cumming *Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Daria KulakovaDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Patrick J ShillingDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Daniel O DaleyDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. ddaley@dbb.su.se.
Stockholm University · SE

Funding

Carl Tryggers Stiftelse för Vetenskaplig Forskning CTS 21:1637Novo Nordisk 0071844
6 · The paper itself

Abstract

pET expression plasmids are widely used for producing recombinant proteins in Escherichia coli. Selection and maintenance of cells harboring a pET plasmid are possible using either a Tn3.1-type genetic fragment (which encodes a ß-lactamase and confers resistance to ß-lactam antibiotics) or a Tn903.1-type genetic fragment (which encodes an aminoglycoside-3'-phosphotransferase and confers resistance aminoglycoside antibiotics). Herein we have investigated how efficiently pET plasmids are maintained using these two fragments. The study reveals that pET plasmids are efficiently maintained with both Tn3.1 and Tn903.1 genetic fragments prior to the induction of recombinant protein production, and over short induction times (i.e., 2 h). However, over longer induction times (i.e., 20 h), the efficiency of plasmid maintenance depends on the host strain used, and the type of antibiotic selection cassette used. Based on our collective observations, we have 2 general tips for efficiently maintaining pET plasmids during recombinant production experiments. Tip #1: Use a strain with lowered levels of the T7 RNA polymerase, such as C41(DE3). pET plasmids will be efficiently maintained over long induction times with both the Tn3.1 and Tn903.1 genetic fragments, regardless of whether antibiotics are present during cultivation. Tip #2: If a strain with higher levels of T7 RNA polymerase strain is necessary, such as BL21(DE3)), keep induction times short or use a plasmid containing a Tn903.1-type fragment and select with kanamycin.

Indexed as

Anti-Bacterial AgentsEscherichia coliAminoglycosidesPlasmidsRecombinant ProteinsAminoglycosidesAnti-Bacterial AgentsRecombinant ProteinsAminoglycoside-3’-phosphotransferaseBacterial cell factorypET expression plasmidPlasmid instabilityPlasmid maintenancePlasmid stabilityß-LactamaseTn3Tn903

Identifiers

PMID37938343
PMCPMC10716060
OpenAlexW4388493061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.